174 related articles for article (PubMed ID: 12464972)
1. Inhibitory effect of polaprezinc on the inflammatory response to Helicobacter pylori.
Handa O; Yoshida N; Tanaka Y; Ueda M; Ishikawa T; Takagi T; Matsumoto N; Naito Y; Yoshikawa T
Can J Gastroenterol; 2002 Nov; 16(11):785-9. PubMed ID: 12464972
[TBL] [Abstract][Full Text] [Related]
2. Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
Suzuki H; Mori M; Seto K; Nagahashi S; Kawaguchi C; Morita H; Suzuki M; Miura S; Yoneta T; Ishii H
J Gastroenterol; 1999; 34 Suppl 11():43-6. PubMed ID: 10616765
[TBL] [Abstract][Full Text] [Related]
3. Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils--a study using intravital videomicroscopy.
Suzuki H; Mori M; Seto K; Miyazawa M; Kai A; Suematsu M; Yoneta T; Miura S; Ishii H
Aliment Pharmacol Ther; 2001 May; 15(5):715-25. PubMed ID: 11328267
[TBL] [Abstract][Full Text] [Related]
4. Residence time of polaprezinc (zinc L-carnosine complex) in the rat stomach and adhesiveness to ulcerous sites.
Furuta S; Toyama S; Miwa M; Itabashi T; Sano H; Yoneta T
Jpn J Pharmacol; 1995 Apr; 67(4):271-8. PubMed ID: 7650862
[TBL] [Abstract][Full Text] [Related]
5. Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-kappaB activiation and interleukin-8 expression in gastric epithelial cells.
Shimada T; Watanabe N; Ohtsuka Y; Endoh M; Kojima K; Hiraishi H; Terano A
J Pharmacol Exp Ther; 1999 Oct; 291(1):345-52. PubMed ID: 10490923
[TBL] [Abstract][Full Text] [Related]
6. Applicability of zinc complex of L-carnosine for medical use.
Matsukura T; Tanaka H
Biochemistry (Mosc); 2000 Jul; 65(7):817-23. PubMed ID: 10951100
[TBL] [Abstract][Full Text] [Related]
7. Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils.
Ishihara R; Iishi H; Sakai N; Yano H; Uedo N; Narahara H; Iseki K; Mikuni T; Ishiguro S; Tatsuta M
Helicobacter; 2002 Dec; 7(6):384-9. PubMed ID: 12485126
[TBL] [Abstract][Full Text] [Related]
8. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells.
Fuji Y; Matsura T; Kai M; Kawasaki H; Yamada K
Jpn J Pharmacol; 2000 Sep; 84(1):63-70. PubMed ID: 11043455
[TBL] [Abstract][Full Text] [Related]
9. [Polaprezinc].
Kuwayama H; Takahashi M; Suzuki K; Suga M; Takata H; Ohara T; Koizumi K; Kiriyama Y
Nihon Rinsho; 2002 Feb; 60 Suppl 2():717-20. PubMed ID: 11979877
[No Abstract] [Full Text] [Related]
10. Polaprezinc protects gastric mucosal cells from noxious agents through antioxidant properties in vitro.
Hiraishi H; Sasai T; Oinuma T; Shimada T; Sugaya H; Terano A
Aliment Pharmacol Ther; 1999 Feb; 13(2):261-9. PubMed ID: 10102958
[TBL] [Abstract][Full Text] [Related]
11. Effect of polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc), a novel antiulcer agent containing zinc, on cellular proliferation: role of insulin-like growth factor I.
Seto K; Yoneta T; Suda H; Tamaki H
Biochem Pharmacol; 1999 Jul; 58(2):245-50. PubMed ID: 10423164
[TBL] [Abstract][Full Text] [Related]
12. Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury.
Naito Y; Yoshikawa T; Yagi N; Matsuyama K; Yoshida N; Seto K; Yoneta T
Dig Dis Sci; 2001 Apr; 46(4):845-51. PubMed ID: 11330422
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
14. Ginger extract and polaprezinc exert gastroprotective actions by anti-oxidant and growth factor modulating effects in rats.
Ko JK; Leung CC
J Gastroenterol Hepatol; 2010 Dec; 25(12):1861-8. PubMed ID: 21091998
[TBL] [Abstract][Full Text] [Related]
15. Ulcerogenic and healing impairing actions of monochloramine in rat stomachs: effects of zinc L-carnosine, polaprezinc.
Nishiwaki H; Kato S; Sugamoto S; Umeda M; Morita H; Yoneta T; Takeuchi K
J Physiol Pharmacol; 1999 Jun; 50(2):183-95. PubMed ID: 10424716
[TBL] [Abstract][Full Text] [Related]
16. Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.
Murakami-Nakayama M; Tsubota M; Hiruma S; Sekiguchi F; Matsuyama K; Kimura T; Moriyama M; Kawabata A
J Pharmacol Sci; 2015 Feb; 127(2):223-8. PubMed ID: 25727961
[TBL] [Abstract][Full Text] [Related]
17. Irritant action of monochloramine in rat stomachs: effects of zinc L-carnosine (polaprezinc).
Nishiwaki H; Kato S; Takeuchi K
Gen Pharmacol; 1997 Nov; 29(5):713-8. PubMed ID: 9347315
[TBL] [Abstract][Full Text] [Related]
18. The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
Choi HS; Lim JY; Chun HJ; Lee M; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Kim CD; Ryu HS; Sul D
Life Sci; 2013 Jul; 93(2-3):69-77. PubMed ID: 23743168
[TBL] [Abstract][Full Text] [Related]
19. Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate.
Kato S; Nishiwaki H; Konaka A; Takeuchi K
Dig Dis Sci; 1997 Oct; 42(10):2156-63. PubMed ID: 9365151
[TBL] [Abstract][Full Text] [Related]
20. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice.
Ohkawara T; Takeda H; Kato K; Miyashita K; Kato M; Iwanaga T; Asaka M
Scand J Gastroenterol; 2005 Nov; 40(11):1321-7. PubMed ID: 16334442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
